PL358388A1 - Aktywny hemostatycznie preparat zawierający czynnik vWF, oraz sposób wytwarzania tego preparatu - Google Patents

Aktywny hemostatycznie preparat zawierający czynnik vWF, oraz sposób wytwarzania tego preparatu

Info

Publication number
PL358388A1
PL358388A1 PL01358388A PL35838801A PL358388A1 PL 358388 A1 PL358388 A1 PL 358388A1 PL 01358388 A PL01358388 A PL 01358388A PL 35838801 A PL35838801 A PL 35838801A PL 358388 A1 PL358388 A1 PL 358388A1
Authority
PL
Poland
Prior art keywords
vwf
fraction
active
production
preparation containing
Prior art date
Application number
PL01358388A
Other languages
English (en)
Other versions
PL203508B1 (pl
Inventor
Djuro Josic
Monika Stadler
Gerhard Gruber
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of PL358388A1 publication Critical patent/PL358388A1/pl
Publication of PL203508B1 publication Critical patent/PL203508B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
PL358388A 2000-04-18 2001-04-04 Sposób uzyskiwania z frakcji osocza ludzkiego preparatu aktywnego hemostatycznie oraz preparat aktywny hemostatycznie otrzymany tym sposobem PL203508B1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00108430.0 2000-04-18
EP00108430A EP1148063A1 (de) 2000-04-18 2000-04-18 Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
PCT/EP2001/003819 WO2001079260A1 (de) 2000-04-18 2001-04-04 Haemostatisch aktives vwf enthaltendes präparat und verfahren zu seiner herstellung

Publications (2)

Publication Number Publication Date
PL358388A1 true PL358388A1 (pl) 2004-08-09
PL203508B1 PL203508B1 (pl) 2009-10-30

Family

ID=

Also Published As

Publication number Publication date
IL152173A (en) 2007-07-24
CN1425024A (zh) 2003-06-18
US7166709B2 (en) 2007-01-23
CZ303932B6 (cs) 2013-07-03
WO2001079260A1 (de) 2001-10-25
US20030138913A1 (en) 2003-07-24
SI1274721T1 (sl) 2006-04-30
ATE306494T1 (de) 2005-10-15
HUP0301211A2 (hu) 2003-07-28
EE200200595A (et) 2004-04-15
BR0110193A (pt) 2003-02-11
CN100448888C (zh) 2009-01-07
RS50835B (sr) 2010-08-31
IL152173A0 (en) 2003-05-29
CA2406626C (en) 2012-02-21
CZ20023454A3 (cs) 2003-05-14
NO20025007D0 (no) 2002-10-17
AU2001263835B2 (en) 2005-06-09
JP2004516231A (ja) 2004-06-03
KR100685448B1 (ko) 2007-02-23
EA200201104A1 (ru) 2003-04-24
HU225992B1 (en) 2008-02-28
JP4976634B2 (ja) 2012-07-18
EP1274721B1 (de) 2005-10-12
ZA200208396B (en) 2004-04-30
YU78402A (sh) 2006-08-17
EP1148063A1 (de) 2001-10-24
HUP0301211A3 (en) 2005-12-28
EP1274721A1 (de) 2003-01-15
DE50107689D1 (de) 2006-02-23
MXPA02010017A (es) 2003-04-25
US20070232791A1 (en) 2007-10-04
NO20025007L (no) 2002-11-28
CA2406626A1 (en) 2001-10-25
KR20030019352A (ko) 2003-03-06
US7985846B2 (en) 2011-07-26
NO324773B1 (no) 2007-12-10
ES2247117T3 (es) 2006-03-01
UA76714C2 (uk) 2006-09-15
EA006209B1 (ru) 2005-10-27
AU6383501A (en) 2001-10-30
DK1274721T3 (da) 2006-02-13

Similar Documents

Publication Publication Date Title
IL152173A0 (en) Haemostatically active preparation containing vwf and method for the production thereof
DE3668157D1 (de) Hybrid-membran/kryogenverfahren zur reinigung von wasserstoff.
AU5504386A (en) Purification of immunoglobulin g
AU8802998A (en) Process to obtain a high-concentration colloidal silica suspension and product thus obtained
DE69515028D1 (de) Die hocheffiziente herstellung und isolierung von viruspartikeln
CA2248960A1 (en) Stable factor viii/vwf-complex
DE3583941D1 (de) Hohlfasermembran mit selektiver durchlaessigkeit, deren herstellung und verfahren zur scheidung von plasmakomponenten sowie plasmakomponentabscheider.
CA2009946A1 (en) Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof
LV10053A (lv) Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
DK0646594T3 (da) Fremgangsmåde til rensning af proteiner
NO970326D0 (no) Fremgangsmåte for produksjon av biologisk aktivt protein
AU3687593A (en) A method of producing a factor VIII preparation
AU2671488A (en) Isolation of an immunoglobulin rich fraction from whey
AU662084B2 (en) Process for reactivating purified membrane proteins
CA2096888A1 (en) Process for the inactivation of viruses in preparations of proteins
ATE99331T1 (de) Fusionsproteine und herstellung davon.
BR9302452A (pt) Composicao polimerica util como membrana,membrana e processo de formacao de membrana
ES2055875T3 (es) Procedimiento de fabricacion del factor antihemofilico (fviiic) con una pureza muy elevada.
ATE374812T1 (de) Methode zur herstellung von thrombin
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
Tarasov et al. Utilization of lithium-bearing waste of lithium current source production; Utilizatsiya litijsoderzhashchikh otkhodov proizvodstva litievykh khimicheskikh istochnikov toka
DE59707174D1 (de) Verfahren zur weiterleitung mit 100% leitungsauslastung von asynchron übertragenen nachrichtenzellen
RU97105852A (ru) Способ очистки факторов роста кератиноцитов